Patents Assigned to SANTEN PHARMACECUTICAL CO., LTD.
  • Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins
    Publication number: 20050245509
    Abstract: A subject of the present invention is to find utility of a combination of a Rho kinase inhibitor and prostaglandins as a therapeutic agent for glaucoma. Actions of reducing intraocular pressure are complemented and/or enhanced each other by combining the Rho kinase inhibitor with prostaglandins. For the administration mode, each drug can be administered in combination or in mixture.
    Type: Application
    Filed: August 29, 2003
    Publication date: November 3, 2005
    Applicant: SANTEN PHARMACECUTICAL CO., LTD.
    Inventors: Tadashi Nakajima, Takeshi Matsugi, Hideaki Hara